Free Trial

SLB (SLB) Financials

SLB logo
$36.48 +0.48 (+1.32%)
As of 12:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for SLB

Annual Income Statements for SLB

This table shows SLB's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
5,438 2,072 -1,687 -1,505 2,138 -10,137 -10,518 1,881 3,441 4,203 4,461
Consolidated Net Income / (Loss)
5,506 2,135 -1,627 -1,513 2,177 -10,107 -10,486 1,928 3,492 4,275 4,579
Net Income / (Loss) Continuing Operations
5,711 2,135 -1,627 -1,513 2,177 -10,107 -10,486 1,928 3,492 4,275 4,579
Total Pre-Tax Income
7,639 2,881 -1,905 -1,183 2,624 -10,418 -11,298 2,374 4,271 5,282 5,672
Total Operating Income
7,717 2,991 -1,535 2,370 2,835 -10,142 -11,002 2,765 4,151 5,443 5,804
Total Gross Profit
11,182 7,154 3,401 3,897 4,337 4,197 2,601 3,658 5,161 6,563 7,460
Total Revenue
48,580 35,475 27,810 30,440 32,815 32,917 23,601 22,929 28,091 33,135 36,289
Operating Revenue
48,580 35,475 27,810 30,440 32,815 32,917 23,601 22,929 28,091 33,135 36,289
Total Cost of Revenue
37,398 28,321 24,409 26,543 28,478 28,720 21,000 19,271 22,930 26,572 28,829
Operating Cost of Revenue
37,398 28,321 24,409 26,543 28,478 28,720 21,000 19,271 22,930 26,572 28,829
Total Operating Expenses
3,465 4,163 4,936 1,527 1,502 14,339 13,603 893 1,010 1,120 1,656
Selling, General & Admin Expense
475 494 403 432 444 474 365 339 376 364 385
Research & Development Expense
1,217 1,094 1,012 787 702 717 580 554 634 711 749
Restructuring Charge
0.00 0.00 349 308 - - - 0.00 0.00 45 522
Total Other Income / (Expense), net
-78 -110 -370 -3,553 -211 -276 -296 -391 120 -161 -132
Interest Expense
369 346 570 566 575 609 563 539 490 503 512
Interest & Investment Income
291 236 200 224 149 86 267 148 610 342 380
Income Tax Expense
1,928 746 -278 330 447 -311 -812 446 779 1,007 1,093
Net Income / (Loss) Attributable to Noncontrolling Interest
68 63 60 -8.00 39 30 32 47 51 72 118
Basic Earnings per Share
$4.20 $1.63 ($1.24) ($1.08) $1.54 ($7.32) ($7.57) $1.34 $2.43 $2.95 $3.14
Weighted Average Basic Shares Outstanding
1.30B 1.27B 1.36B 1.39B 1.39B 1.39B 1.39B 1.40B 1.42B 1.43B 1.42B
Diluted Earnings per Share
$4.16 $1.63 ($1.24) ($1.08) $1.53 ($7.32) ($7.57) $1.32 $2.39 $2.91 $3.11
Weighted Average Diluted Shares Outstanding
1.31B 1.28B 1.36B 1.39B 1.39B 1.39B 1.39B 1.43B 1.44B 1.44B 1.44B
Weighted Average Basic & Diluted Shares Outstanding
1.29B 1.27B 1.36B 1.39B 1.39B 1.38B 1.39B 1.40B 1.42B 1.43B 1.40B

Quarterly Income Statements for SLB

This table shows SLB's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders
934 1,033 1,123 1,113 1,068 1,112 1,186 1,095 797 1,014 739
Consolidated Net Income / (Loss)
944 1,047 1,136 1,148 1,098 1,145 1,218 1,118 829 1,048 774
Net Income / (Loss) Continuing Operations
944 1,047 1,136 1,148 1,098 1,145 1,218 1,118 829 1,048 774
Total Pre-Tax Income
1,161 1,293 1,395 1,433 1,357 1,421 1,507 1,387 1,063 1,285 1,000
Total Operating Income
1,186 1,338 1,451 1,468 1,386 1,468 1,547 1,403 1,132 1,175 1,064
Total Gross Profit
1,451 1,597 1,718 1,797 1,700 1,877 1,922 1,961 1,606 1,612 1,558
Total Revenue
7,736 8,099 8,310 8,990 8,707 9,139 9,159 9,284 8,490 8,546 8,928
Operating Revenue
7,736 8,099 8,310 8,990 8,707 9,139 9,159 9,284 8,490 8,546 8,928
Total Cost of Revenue
6,285 6,502 6,592 7,193 7,007 7,262 7,237 7,323 6,884 6,934 7,370
Operating Cost of Revenue
6,285 6,502 6,592 7,193 7,007 7,262 7,237 7,323 6,884 6,934 7,370
Total Operating Expenses
265 259 267 329 314 409 375 558 474 437 494
Selling, General & Admin Expense
91 96 81 96 121 94 90 80 96 87 72
Research & Development Expense
174 163 186 188 182 188 187 192 172 180 170
Restructuring Charge
0.00 0.00 0.00 45 11 127 98 286 206 170 252
Total Other Income / (Expense), net
-25 -45 -56 -35 -29 -47 -40 -16 -69 110 -64
Interest Expense
117 127 129 130 113 132 136 131 147 142 142
Interest & Investment Income
92 82 73 95 84 85 96 115 78 252 78
Income Tax Expense
217 246 259 285 259 276 289 269 234 237 226
Net Income / (Loss) Attributable to Noncontrolling Interest
10 14 13 35 30 33 32 23 32 34 35
Basic Earnings per Share
$0.65 $0.73 $0.79 $0.78 $0.75 $0.78 $0.84 $0.77 $0.58 $0.75 $0.50
Weighted Average Basic Shares Outstanding
1.43B 1.42B 1.42B 1.43B 1.43B 1.43B 1.42B 1.42B 1.37B 1.35B 1.47B
Diluted Earnings per Share
$0.65 $0.72 $0.78 $0.76 $0.74 $0.77 $0.83 $0.77 $0.58 $0.74 $0.50
Weighted Average Diluted Shares Outstanding
1.45B 1.44B 1.44B 1.44B 1.45B 1.44B 1.43B 1.44B 1.38B 1.37B 1.49B
Weighted Average Basic & Diluted Shares Outstanding
1.43B 1.42B 1.42B 1.43B 1.43B 1.42B 1.41B 1.40B 1.36B 1.35B 1.49B

Annual Cash Flow Statements for SLB

This table details how cash moves in and out of SLB's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
-257 -306 209 -1,149 -347 -298 -282 908 -50 1,342 685
Net Cash From Operating Activities
11,219 8,572 6,261 5,663 5,713 5,431 2,944 4,651 3,720 6,637 6,602
Net Cash From Continuing Operating Activities
11,195 8,805 6,261 5,663 5,713 5,431 2,944 4,687 3,720 6,637 6,602
Net Income / (Loss) Continuing Operations
5,711 2,135 -1,627 -1,513 2,177 -10,107 -10,486 1,928 3,492 4,275 4,579
Consolidated Net Income / (Loss)
5,506 2,135 -1,627 -1,513 2,177 -10,107 -10,486 1,928 3,492 4,275 4,579
Depreciation Expense
4,094 4,078 4,094 3,837 3,556 3,589 2,566 2,120 2,147 2,312 2,519
Non-Cash Adjustments To Reconcile Net Income
1,954 2,868 4,040 3,918 355 13,312 12,884 238 -130 271 839
Changes in Operating Assets and Liabilities, net
-564 -276 -246 -579 -375 -1,363 -2,020 401 -1,789 -221 -1,335
Net Cash From Investing Activities
-5,580 -10,252 -624 -1,779 -1,040 -2,011 -2,353 -919 -1,388 -2,783 -3,145
Net Cash From Continuing Investing Activities
-5,580 -10,252 -624 -1,779 -1,040 -2,011 -2,353 -919 -1,388 -2,783 -3,145
Purchase of Property, Plant & Equipment
-4,297 -2,896 -2,685 -2,383 -2,260 -1,955 -1,217 -1,180 -2,205 -2,446 -2,414
Acquisitions
-1,008 -443 -2,398 -847 -292 -23 -33 -103 -155 -395 -751
Purchase of Investments
-740 -953 -1,031 -1,609 -981 -781 -303 -474 -121 -68 -239
Sale and/or Maturity of Investments
446 -5,848 5,544 3,277 1,943 317 -1,141 896 1,186 234 152
Other Investing Activities, net
19 -112 -54 -217 -29 -155 -93 -58 -93 -108 107
Net Cash From Financing Activities
-5,896 1,374 -5,428 -5,033 -5,020 -3,718 -873 -2,824 -2,382 -2,512 -2,772
Net Cash From Continuing Financing Activities
-5,896 1,374 -5,428 -5,033 -5,020 -3,718 -873 -2,824 -2,382 -2,512 -2,772
Repayment of Debt
-2,364 -4,038 -6,058 -3,983 -3,009 -4,894 -5,068 -2,272 -1,664 -1,607 -1,135
Repurchase of Common Equity
-4,678 -2,182 -778 -969 -400 -278 -26 0.00 0.00 -694 -1,737
Payment of Dividends
-1,968 -2,419 -2,647 -2,778 -2,770 -2,769 -1,734 -699 -848 -1,317 -1,533
Issuance of Debt
2,289 9,565 3,640 2,400 898 4,004 5,837 34 0.00 994 1,475
Issuance of Common Equity
295 296 231 212 227 196 146 137 142 191 219
Other Financing Activities, net
530 152 184 85 34 23 -28 -24 -12 -79 -61

Quarterly Cash Flow Statements for SLB

This table details how cash moves in and out of SLB's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Net Change in Cash & Equivalents
-155 442 562 493 -91 164 130 482 -650 277 -206
Net Cash From Operating Activities
330 1,608 1,677 3,022 327 1,436 2,449 2,390 660 1,142 1,682
Net Cash From Continuing Operating Activities
330 1,608 1,677 3,022 327 1,436 2,449 2,390 660 1,142 1,682
Net Income / (Loss) Continuing Operations
944 1,046 1,137 1,148 1,098 1,145 1,218 1,118 829 1,048 774
Consolidated Net Income / (Loss)
944 1,046 1,137 1,148 1,098 1,145 1,218 1,118 829 1,048 774
Depreciation Expense
563 561 579 609 600 631 640 648 640 633 638
Non-Cash Adjustments To Reconcile Net Income
13 32 17 209 84 243 162 325 81 -40 129
Changes in Operating Assets and Liabilities, net
-1,190 -31 -56 1,056 -1,455 -583 429 299 -890 -499 141
Net Cash From Investing Activities
-547 -983 -733 -520 -151 -1,493 -1,024 -477 -432 246 44
Net Cash From Continuing Investing Activities
-547 -983 -733 -520 -151 -1,493 -1,024 -477 -432 246 44
Purchase of Property, Plant & Equipment
-462 -502 -502 -980 -399 -525 -510 -951 -398 -371 -409
Acquisitions
-244 -18 -18 -115 -56 -478 -47 -199 -88 -42 297
Purchase of Investments
-133 -120 -319 504 -173 -135 -538 555 -183 -165 -131
Divestitures
- - - - - - - - - - 22
Sale and/or Maturity of Investments
373 -260 115 6.00 424 -343 45 60 240 494 -18
Other Investing Activities, net
-81 -83 -9.00 65 53 -12 26 58 -3.00 14 283
Net Cash From Financing Activities
62 -183 -382 -2,009 -267 221 -1,295 -1,431 -878 -1,111 -1,932
Net Cash From Continuing Financing Activities
62 -183 -382 -2,009 -267 221 -1,295 -1,431 -878 -1,111 -1,932
Repayment of Debt
-51 6.00 -9.00 -1,553 -22 -429 -143 -541 -57 2.00 -1,105
Repurchase of Common Equity
-230 -213 -151 -100 -270 -465 -501 -501 -2,300 - -114
Payment of Dividends
-249 -356 -356 -356 -357 -394 -393 -389 -386 -387 -403
Issuance of Debt
559 433 - 2.00 345 1,504 -374 - 1,805 -724 -421
Issuance of Common Equity
86 - 105 - 100 - 119 - 105 - 117
Other Financing Activities, net
-53 -53 29 -2.00 -63 5.00 -3.00 - -45 -2.00 -6.00

Annual Balance Sheets for SLB

This table presents SLB's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
66,904 68,005 77,956 71,987 70,507 56,312 42,434 41,511 43,135 47,957 48,935
Total Current Assets
24,694 26,912 23,927 18,497 15,731 15,530 12,919 12,654 15,003 17,718 18,570
Cash & Equivalents
3,130 2,793 2,929 1,799 1,433 1,137 844 1,757 1,655 2,900 3,544
Short-Term Investments
4,371 10,241 6,328 3,290 1,344 1,030 2,162 1,382 1,239 1,089 1,125
Accounts Receivable
11,171 8,780 9,387 8,084 7,881 7,747 5,247 5,315 6,766 7,812 8,011
Inventories, net
4,628 3,756 4,225 4,046 4,010 4,130 3,354 3,272 3,999 4,387 4,375
Other Current Assets
1,250 1,134 1,058 1,278 1,063 1,486 1,312 928 1,344 1,530 1,515
Plant, Property, & Equipment, net
15,396 13,415 12,821 11,576 11,679 9,270 6,826 6,429 6,607 7,240 7,359
Total Noncurrent Assets
26,814 27,678 41,208 41,914 43,097 31,512 22,689 22,428 21,525 22,999 23,006
Long-Term Investments
3,677 3,729 1,481 1,519 1,538 1,565 2,061 2,044 1,581 1,624 1,635
Goodwill
15,487 15,605 24,990 25,118 24,931 16,042 12,980 12,990 12,982 14,084 14,593
Intangible Assets
4,654 4,569 9,855 9,354 8,727 7,089 3,455 3,211 2,992 3,239 3,012
Other Noncurrent Operating Assets
2,996 3,775 4,882 5,923 7,901 6,816 4,193 4,183 3,970 4,052 3,766
Total Liabilities & Shareholders' Equity
66,904 68,005 77,956 71,987 70,507 56,312 42,434 41,511 43,135 47,957 48,935
Total Liabilities
28,855 32,100 36,427 34,726 33,921 32,136 29,945 26,225 25,146 26,598 26,585
Total Current Liabilities
14,176 14,121 15,059 15,282 13,486 13,098 10,491 10,359 12,018 13,395 12,811
Short-Term Debt
2,765 4,557 3,153 3,324 1,407 524 850 909 1,632 1,123 1,051
Accounts Payable
9,246 7,727 10,016 10,036 10,223 10,663 8,442 8,382 9,121 10,904 10,375
Dividends Payable
518 634 702 699 701 702 184 189 263 374 403
Current Deferred & Payable Income Tax Liabilities
1,647 1,203 1,188 1,223 1,155 1,209 1,015 879 1,002 994 982
Total Noncurrent Liabilities
14,679 17,979 21,368 19,444 20,435 19,038 19,454 15,866 13,128 13,203 13,774
Long-Term Debt
10,565 14,442 16,463 14,875 14,644 14,770 16,036 13,286 10,594 10,842 11,023
Noncurrent Deferred & Payable Income Tax Liabilities
1,296 1,075 1,880 1,650 1,441 491 19 94 61 140 67
Noncurrent Employee Benefit Liabilities
1,501 1,434 1,495 1,082 1,153 967 1,049 231 165 175 512
Other Noncurrent Operating Liabilities
1,317 1,028 1,530 1,837 3,197 2,810 2,350 2,255 2,308 2,046 2,172
Total Equity & Noncontrolling Interests
38,049 35,905 41,529 37,261 36,586 24,176 12,489 15,286 17,989 21,359 22,350
Total Preferred & Common Equity
37,850 35,633 41,078 36,842 36,162 23,760 12,071 15,004 17,685 20,189 21,130
Total Common Equity
37,850 35,633 41,078 36,842 36,162 23,760 12,071 15,004 17,685 20,189 21,130
Common Stock
12,495 12,693 12,801 12,975 13,132 13,078 12,970 12,608 11,837 11,624 11,458
Retained Earnings
41,333 40,870 36,470 32,190 31,658 18,751 7,018 8,199 10,719 13,497 16,395
Treasury Stock
-11,772 -13,372 -3,550 -4,049 -4,006 -3,631 -3,033 -2,233 -1,016 -678 -1,773
Accumulated Other Comprehensive Income / (Loss)
-4,206 -4,558 -4,643 -4,274 -4,622 -4,438 -4,884 -3,570 -3,855 -4,254 -4,950
Noncontrolling Interest
199 272 451 419 424 416 418 282 304 1,170 1,220

Quarterly Balance Sheets for SLB

This table presents SLB's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets
43,855 44,826 45,813 47,957 47,856 49,373 49,775 48,935 49,002 48,769 55,093
Total Current Assets
15,400 16,154 17,038 17,718 17,700 18,517 18,801 18,570 18,595 18,453 19,468
Cash & Equivalents
1,501 1,930 2,488 2,900 2,788 2,953 3,086 3,544 2,936 3,236 3,014
Short-Term Investments
1,003 1,264 1,247 1,089 703 1,050 1,376 1,125 961 511 571
Accounts Receivable
7,578 7,675 8,049 7,812 8,222 8,605 8,260 8,011 8,604 8,586 9,101
Inventories, net
4,286 4,360 4,305 4,387 4,549 4,504 4,573 4,375 4,650 4,740 5,321
Other Current Assets
1,032 925 949 1,530 1,438 1,405 1,506 1,515 1,444 1,380 1,461
Plant, Property, & Equipment, net
6,691 6,804 6,875 7,240 7,253 7,335 7,360 7,359 7,399 7,399 7,999
Total Noncurrent Assets
21,764 21,868 21,900 22,999 22,903 23,521 23,614 23,006 23,008 22,917 27,626
Long-Term Investments
1,554 1,601 1,622 1,624 1,606 1,678 1,744 1,635 1,641 1,676 1,691
Goodwill
13,113 13,117 13,111 14,084 14,086 14,530 14,559 14,593 14,637 14,658 17,007
Intangible Assets
3,021 2,968 2,912 3,239 3,167 3,198 3,122 3,012 2,963 2,893 5,089
Other Noncurrent Operating Assets
4,076 4,182 4,255 4,052 4,044 4,115 4,189 3,766 3,767 3,690 3,839
Total Liabilities & Shareholders' Equity
43,855 44,826 45,813 47,957 47,856 49,373 49,775 48,935 49,002 48,769 55,093
Total Liabilities
25,475 25,892 26,106 26,598 25,933 27,093 27,047 26,585 28,254 27,218 28,171
Total Current Liabilities
12,252 12,163 12,528 13,395 12,879 12,409 12,699 12,811 15,036 14,035 14,037
Short-Term Debt
2,140 1,993 1,998 1,123 1,430 1,033 1,059 1,051 3,475 2,807 1,923
Accounts Payable
8,700 8,938 9,222 10,904 10,051 10,099 10,346 10,375 10,221 9,993 10,857
Dividends Payable
374 373 373 374 411 410 406 403 404 402 443
Current Deferred & Payable Income Tax Liabilities
1,038 859 935 994 987 867 888 982 936 833 814
Total Noncurrent Liabilities
13,223 13,729 13,578 13,203 13,054 14,684 14,348 13,774 13,218 13,183 14,134
Long-Term Debt
10,698 11,342 11,147 10,842 10,740 12,156 11,864 11,023 10,527 10,891 10,843
Noncurrent Deferred & Payable Income Tax Liabilities
194 183 157 140 115 135 171 67 37 12 827
Noncurrent Employee Benefit Liabilities
168 167 166 175 177 175 176 512 507 502 502
Other Noncurrent Operating Liabilities
2,163 2,037 2,108 2,046 2,022 2,218 2,137 2,172 2,147 1,778 1,962
Total Equity & Noncontrolling Interests
18,380 18,934 19,707 21,359 21,923 22,280 22,728 22,350 20,748 21,551 26,922
Total Preferred & Common Equity
18,068 18,608 19,386 20,189 20,736 21,071 21,511 21,130 19,515 20,302 25,635
Total Common Equity
18,068 18,608 19,386 20,189 20,736 21,071 21,511 21,130 19,515 20,302 25,635
Common Stock
11,264 11,270 11,182 11,624 11,344 11,401 11,408 11,458 10,827 11,354 16,338
Retained Earnings
11,296 11,974 12,742 13,497 14,172 14,890 15,687 16,395 16,804 17,433 17,746
Treasury Stock
-559 -750 -621 -678 -531 -973 -1,294 -1,773 -3,292 -3,742 -3,636
Accumulated Other Comprehensive Income / (Loss)
-3,933 -3,886 -3,917 -4,254 -4,249 -4,247 -4,290 -4,950 -4,824 -4,743 -4,813
Noncontrolling Interest
312 326 321 1,170 1,187 1,209 1,217 1,220 1,233 1,249 1,287

Annual Metrics And Ratios for SLB

This table displays calculated financial ratios and metrics derived from SLB's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.32% -26.98% -21.61% 9.46% 7.80% 0.31% -28.30% -2.85% 22.51% 17.96% 9.52%
EBITDA Growth
-7.70% -40.15% -63.80% 17.08% 120.49% -195.46% -33.78% 157.91% 28.93% 23.13% 7.32%
EBIT Growth
-13.46% -61.24% -151.32% 45.21% 462.66% -424.43% -11.19% 125.13% 50.13% 31.13% 6.63%
NOPAT Growth
-7.12% -61.58% -148.48% 254.40% 41.78% -401.84% -8.48% 129.16% 51.14% 29.80% 6.36%
Net Income Growth
-18.72% -61.22% -176.21% 7.01% 243.89% -564.26% -3.75% 118.39% 81.12% 22.42% 7.11%
EPS Growth
-17.62% -60.82% -176.07% 12.90% 241.67% -578.43% -3.42% 117.44% 81.06% 21.76% 6.87%
Operating Cash Flow Growth
4.97% -23.59% -26.96% -9.55% 0.88% -4.94% -45.79% 57.98% -20.02% 78.41% -0.53%
Free Cash Flow Firm Growth
60.86% -33.18% -422.28% 123.99% -10.47% 90.40% -22.56% -47.00% -16.56% 23.72% 82.82%
Invested Capital Growth
-1.11% -4.77% 31.81% -3.05% -1.07% -25.67% -32.79% -0.02% 6.19% 8.01% 1.56%
Revenue Q/Q Growth
1.54% -12.13% -2.24% 3.65% 0.00% 0.15% -10.25% 3.12% 6.26% 3.47% 0.82%
EBITDA Q/Q Growth
-3.07% -21.37% 66.49% -41.31% -4.63% -0.67% -1.75% 7.48% 8.18% 3.11% -0.31%
EBIT Q/Q Growth
-5.52% -37.82% 38.70% -172.63% -9.87% 0.29% 1.08% 16.47% 12.43% 3.30% -1.11%
NOPAT Q/Q Growth
-9.22% -37.12% 38.70% 106.66% -0.71% -2.20% 1.08% 16.34% 11.98% 3.19% -0.95%
Net Income Q/Q Growth
-19.85% -37.99% 32.85% -367.79% 438.57% -2.08% 0.39% 13.41% 15.63% 1.54% -0.65%
EPS Q/Q Growth
-19.38% -38.95% 31.87% -427.27% 425.53% -1.81% 0.39% 11.86% 14.90% 1.04% 0.32%
Operating Cash Flow Q/Q Growth
-1.80% -16.83% -2.57% 4.39% 1.42% -1.43% -31.82% 29.30% -7.88% 26.93% -8.74%
Free Cash Flow Firm Q/Q Growth
89.16% -37.85% -1.19% 110.84% -8.10% -2.97% -19.04% -18.96% 27.52% 7.80% 54.59%
Invested Capital Q/Q Growth
-7.10% -4.64% -2.02% -3.67% -3.25% -4.29% -2.20% 1.20% 0.97% 0.78% -4.45%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
23.02% 20.17% 12.23% 12.80% 13.22% 12.75% 11.02% 15.95% 18.37% 19.81% 20.56%
EBITDA Margin
24.31% 19.93% 9.20% 9.84% 20.13% -19.16% -35.74% 21.30% 22.42% 23.40% 22.94%
Operating Margin
15.89% 8.43% -5.52% 7.79% 8.64% -30.81% -46.62% 12.06% 14.78% 16.43% 15.99%
EBIT Margin
15.89% 8.43% -5.52% -2.76% 9.29% -30.06% -46.62% 12.06% 14.78% 16.43% 15.99%
Profit (Net Income) Margin
11.33% 6.02% -5.85% -4.97% 6.63% -30.70% -44.43% 8.41% 12.43% 12.90% 12.62%
Tax Burden Percent
72.08% 74.11% 85.41% 127.90% 82.96% 97.01% 92.81% 81.21% 81.76% 80.94% 80.73%
Interest Burden Percent
98.99% 96.32% 124.10% 140.67% 86.03% 105.29% 102.69% 85.86% 102.89% 97.04% 97.73%
Effective Tax Rate
25.24% 25.89% 0.00% 0.00% 17.04% 0.00% 0.00% 18.79% 18.24% 19.06% 19.27%
Return on Invested Capital (ROIC)
14.09% 5.58% -2.39% 3.30% 4.77% -16.61% -25.28% 9.17% 13.44% 16.29% 16.55%
ROIC Less NNEP Spread (ROIC-NNEP)
1.58% 2.63% -11.27% -25.71% 3.36% -40.97% -48.23% 6.17% 14.58% 14.52% 14.90%
Return on Net Nonoperating Assets (RNNOA)
0.09% 0.20% -1.81% -7.14% 1.12% -16.65% -31.92% 4.71% 7.54% 5.44% 4.40%
Return on Equity (ROE)
14.18% 5.77% -4.20% -3.84% 5.90% -33.27% -57.20% 13.88% 20.99% 21.73% 20.95%
Cash Return on Invested Capital (CROIC)
15.21% 10.47% -29.84% 6.39% 5.84% 12.83% 13.94% 9.19% 7.44% 8.59% 15.01%
Operating Return on Assets (OROA)
11.52% 4.43% -2.10% -1.12% 4.28% -15.60% -22.28% 6.59% 9.81% 11.95% 11.98%
Return on Assets (ROA)
8.22% 3.17% -2.23% -2.02% 3.06% -15.94% -21.24% 4.59% 8.25% 9.39% 9.45%
Return on Common Equity (ROCE)
14.11% 5.74% -4.16% -3.80% 5.83% -32.81% -55.90% 13.53% 20.62% 20.92% 19.81%
Return on Equity Simple (ROE_SIMPLE)
14.55% 5.99% -3.96% -4.11% 6.02% -42.54% -86.87% 12.85% 19.75% 21.17% 21.67%
Net Operating Profit after Tax (NOPAT)
5,769 2,217 -1,075 1,659 2,352 -7,099 -7,701 2,246 3,394 4,405 4,686
NOPAT Margin
11.88% 6.25% -3.86% 5.45% 7.17% -21.57% -32.63% 9.79% 12.08% 13.30% 12.91%
Net Nonoperating Expense Percent (NNEP)
12.51% 2.94% 8.88% 29.01% 1.42% 24.35% 22.95% 3.00% -1.14% 1.77% 1.65%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - 11.23% 13.22% 13.61%
Cost of Revenue to Revenue
76.98% 79.83% 87.77% 87.20% 86.78% 87.25% 88.98% 84.05% 81.63% 80.19% 79.44%
SG&A Expenses to Revenue
0.98% 1.39% 1.45% 1.42% 1.35% 1.44% 1.55% 1.48% 1.34% 1.10% 1.06%
R&D to Revenue
2.51% 3.08% 3.64% 2.59% 2.14% 2.18% 2.46% 2.42% 2.26% 2.15% 2.06%
Operating Expenses to Revenue
7.13% 11.74% 17.75% 5.02% 4.58% 43.56% 57.64% 3.89% 3.60% 3.38% 4.56%
Earnings before Interest and Taxes (EBIT)
7,717 2,991 -1,535 -841 3,050 -9,895 -11,002 2,765 4,151 5,443 5,804
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
11,811 7,069 2,559 2,996 6,606 -6,306 -8,436 4,885 6,298 7,755 8,323
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.20 1.92 2.27 2.09 1.18 2.11 2.35 2.67 4.10 3.58 2.56
Price to Tangible Book Value (P/TBV)
4.70 4.42 14.93 32.56 17.05 79.87 0.00 0.00 42.40 25.21 15.36
Price to Revenue (P/Rev)
1.71 1.92 3.35 2.53 1.30 1.53 1.20 1.75 2.58 2.18 1.49
Price to Earnings (P/E)
15.31 32.95 0.00 0.00 19.96 0.00 0.00 21.33 21.08 17.19 12.14
Dividend Yield
2.47% 3.69% 2.99% 4.49% 6.49% 5.51% 4.29% 2.18% 1.27% 1.97% 2.87%
Earnings Yield
6.53% 3.03% 0.00% 0.00% 5.01% 0.00% 0.00% 4.69% 4.74% 5.82% 8.24%
Enterprise Value to Invested Capital (EV/IC)
2.10 1.83 2.00 1.80 1.12 1.71 1.66 2.02 3.10 2.84 2.14
Enterprise Value to Revenue (EV/Rev)
1.76 2.00 3.68 2.93 1.67 1.89 1.72 2.16 2.87 2.41 1.68
Enterprise Value to EBITDA (EV/EBITDA)
7.25 10.01 40.00 29.76 8.30 0.00 0.00 10.12 12.80 10.29 7.34
Enterprise Value to EBIT (EV/EBIT)
11.09 23.66 0.00 0.00 17.98 0.00 0.00 17.87 19.42 14.66 10.53
Enterprise Value to NOPAT (EV/NOPAT)
14.84 31.93 0.00 53.75 23.32 0.00 0.00 22.01 23.75 18.11 13.05
Enterprise Value to Operating Cash Flow (EV/OCF)
7.63 8.26 16.35 15.75 9.60 11.46 13.80 10.63 21.67 12.02 9.26
Enterprise Value to Free Cash Flow (EV/FCFF)
13.75 17.01 0.00 27.72 19.04 11.35 9.57 21.96 42.92 34.34 14.39
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.35 0.53 0.47 0.49 0.44 0.63 1.35 0.93 0.68 0.56 0.54
Long-Term Debt to Equity
0.28 0.40 0.40 0.40 0.40 0.61 1.28 0.87 0.59 0.51 0.49
Financial Leverage
0.05 0.07 0.16 0.28 0.33 0.41 0.66 0.76 0.52 0.37 0.30
Leverage Ratio
1.73 1.82 1.89 1.90 1.93 2.09 2.69 3.02 2.54 2.32 2.22
Compound Leverage Factor
1.71 1.76 2.34 2.68 1.66 2.20 2.77 2.59 2.62 2.25 2.17
Debt to Total Capital
25.94% 34.60% 32.08% 32.81% 30.49% 38.75% 57.48% 48.15% 40.46% 35.91% 35.07%
Short-Term Debt to Total Capital
5.38% 8.30% 5.16% 5.99% 2.67% 1.33% 2.89% 3.08% 5.40% 3.37% 3.05%
Long-Term Debt to Total Capital
20.56% 26.30% 26.92% 26.82% 27.82% 37.42% 54.59% 45.07% 35.06% 32.54% 32.02%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.39% 0.50% 0.74% 0.76% 0.81% 1.05% 1.42% 0.96% 1.01% 3.51% 3.54%
Common Equity to Total Capital
73.67% 64.90% 67.18% 66.43% 68.70% 60.20% 41.09% 50.89% 58.53% 60.58% 61.38%
Debt to EBITDA
1.13 2.69 7.67 6.07 2.43 -2.43 -2.00 2.91 1.94 1.54 1.45
Net Debt to EBITDA
0.18 0.32 3.47 3.87 1.78 -1.83 -1.40 1.84 1.23 0.82 0.69
Long-Term Debt to EBITDA
0.89 2.04 6.43 4.97 2.22 -2.34 -1.90 2.72 1.68 1.40 1.32
Debt to NOPAT
2.31 8.57 -18.26 10.97 6.82 -2.15 -2.19 6.32 3.60 2.72 2.58
Net Debt to NOPAT
0.37 1.01 -8.26 6.99 4.99 -1.63 -1.53 4.01 2.28 1.44 1.23
Long-Term Debt to NOPAT
1.83 6.52 -15.32 8.97 6.23 -2.08 -2.08 5.92 3.12 2.46 2.35
Altman Z-Score
3.89 3.01 2.62 2.40 2.03 1.46 0.57 2.03 3.13 3.20 2.97
Noncontrolling Interest Sharing Ratio
0.47% 0.64% 0.93% 1.10% 1.14% 1.38% 2.27% 2.52% 1.76% 3.75% 5.47%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.74 1.91 1.59 1.21 1.17 1.19 1.23 1.22 1.25 1.32 1.45
Quick Ratio
1.32 1.54 1.24 0.86 0.79 0.76 0.79 0.82 0.80 0.88 0.99
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
6,226 4,161 -13,409 3,217 2,880 5,484 4,247 2,251 1,878 2,323 4,248
Operating Cash Flow to CapEx
261.09% 295.99% 233.18% 237.64% 252.79% 277.80% 241.91% 394.15% 168.71% 271.34% 273.49%
Free Cash Flow to Firm to Interest Expense
16.87 12.02 -23.52 5.68 5.01 9.00 7.54 4.18 3.83 4.62 8.30
Operating Cash Flow to Interest Expense
30.40 24.77 10.98 10.01 9.94 8.92 5.23 8.63 7.59 13.19 12.89
Operating Cash Flow Less CapEx to Interest Expense
18.76 16.40 6.27 5.80 6.01 5.71 3.07 6.44 3.09 8.33 8.18
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.73 0.53 0.38 0.41 0.46 0.52 0.48 0.55 0.66 0.73 0.75
Accounts Receivable Turnover
4.29 3.56 3.06 3.48 4.11 4.21 3.63 4.34 4.65 4.55 4.59
Inventory Turnover
8.10 6.76 6.12 6.42 7.07 7.06 5.61 5.82 6.31 6.34 6.58
Fixed Asset Turnover
3.19 2.46 2.12 2.50 2.82 3.14 2.93 3.46 4.31 4.79 4.97
Accounts Payable Turnover
4.14 3.34 2.75 2.65 2.81 2.75 2.20 2.29 2.62 2.65 2.71
Days Sales Outstanding (DSO)
85.16 102.64 119.22 104.75 88.79 86.65 100.48 84.07 78.49 80.29 79.58
Days Inventory Outstanding (DIO)
45.05 54.03 59.67 56.87 51.63 51.73 65.04 62.75 57.87 57.60 55.47
Days Payable Outstanding (DPO)
88.24 109.37 132.66 137.87 129.83 132.72 166.03 159.33 139.31 137.53 134.71
Cash Conversion Cycle (CCC)
41.96 47.29 46.23 23.74 10.59 5.65 -0.51 -12.51 -2.95 0.35 0.34
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
40,719 38,775 51,109 49,551 49,023 36,440 24,492 24,487 26,003 28,085 28,523
Invested Capital Turnover
1.19 0.89 0.62 0.60 0.67 0.77 0.77 0.94 1.11 1.23 1.28
Increase / (Decrease) in Invested Capital
-457 -1,944 12,334 -1,558 -528 -12,583 -11,948 -5.00 1,516 2,082 438
Enterprise Value (EV)
85,596 70,780 102,371 89,166 54,845 62,215 40,620 49,417 80,597 79,777 61,132
Market Capitalization
83,245 68,272 93,042 77,156 42,685 50,237 28,383 40,123 72,542 72,255 54,142
Book Value per Share
$29.41 $28.26 $29.52 $26.60 $26.11 $17.16 $8.67 $10.70 $12.47 $14.18 $14.96
Tangible Book Value per Share
$13.76 $12.26 $4.48 $1.71 $1.81 $0.45 ($3.14) ($0.85) $1.21 $2.01 $2.50
Total Capital
51,379 54,904 61,145 55,460 52,637 39,470 29,375 29,481 30,215 33,324 34,424
Total Debt
13,330 18,999 19,616 18,199 16,051 15,294 16,886 14,195 12,226 11,965 12,074
Total Long-Term Debt
10,565 14,442 16,463 14,875 14,644 14,770 16,036 13,286 10,594 10,842 11,023
Net Debt
2,152 2,236 8,878 11,591 11,736 11,562 11,819 9,012 7,751 6,352 5,770
Capital Expenditures (CapEx)
4,297 2,896 2,685 2,383 2,260 1,955 1,217 1,180 2,205 2,446 2,414
Debt-free, Cash-free Net Working Capital (DFCFNWC)
5,782 4,314 2,764 1,450 875 789 272 65 1,723 1,457 2,141
Debt-free Net Working Capital (DFNWC)
13,283 17,348 12,021 6,539 3,652 2,956 3,278 3,204 4,617 5,446 6,810
Net Working Capital (NWC)
10,518 12,791 8,868 3,215 2,245 2,432 2,428 2,295 2,985 4,323 5,759
Net Nonoperating Expense (NNE)
263 82 553 3,172 175 3,008 2,785 318 -98 130 107
Net Nonoperating Obligations (NNO)
2,670 2,870 9,580 12,290 12,437 12,264 12,003 9,201 8,014 6,726 6,173
Total Depreciation and Amortization (D&A)
4,094 4,078 4,094 3,837 3,556 3,589 2,566 2,120 2,147 2,312 2,519
Debt-free, Cash-free Net Working Capital to Revenue
11.90% 12.16% 9.94% 4.76% 2.67% 2.40% 1.15% 0.28% 6.13% 4.40% 5.90%
Debt-free Net Working Capital to Revenue
27.34% 48.90% 43.23% 21.48% 11.13% 8.98% 13.89% 13.97% 16.44% 16.44% 18.77%
Net Working Capital to Revenue
21.65% 36.06% 31.89% 10.56% 6.84% 7.39% 10.29% 10.01% 10.63% 13.05% 15.87%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.20 $1.63 ($1.24) ($1.08) $1.54 ($7.32) ($7.57) $1.34 $2.43 $2.95 $3.14
Adjusted Weighted Average Basic Shares Outstanding
1.30B 1.27B 1.36B 1.39B 1.39B 1.39B 1.39B 1.40B 1.42B 1.43B 1.42B
Adjusted Diluted Earnings per Share
$4.16 $1.63 ($1.24) ($1.08) $1.53 ($7.32) ($7.57) $1.32 $2.39 $2.91 $3.11
Adjusted Weighted Average Diluted Shares Outstanding
1.31B 1.28B 1.36B 1.39B 1.39B 1.39B 1.39B 1.43B 1.44B 1.44B 1.44B
Adjusted Basic & Diluted Earnings per Share
$4.20 $0.00 $0.00 $0.00 $0.00 ($7.32) $0.00 $1.34 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.28B 1.26B 1.39B 1.38B 1.38B 1.38B 1.39B 1.40B 1.42B 1.43B 1.40B
Normalized Net Operating Profit after Tax (NOPAT)
7,095 4,125 1,390 1,875 2,647 2,104 1,159 2,246 3,394 4,442 5,107
Normalized NOPAT Margin
14.60% 11.63% 5.00% 6.16% 8.07% 6.39% 4.91% 9.79% 12.08% 13.40% 14.07%
Pre Tax Income Margin
15.72% 8.12% -6.85% -3.89% 8.00% -31.65% -47.87% 10.35% 15.20% 15.94% 15.63%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
20.91 8.64 -2.69 -1.49 5.30 -16.25 -19.54 5.13 8.47 10.82 11.34
NOPAT to Interest Expense
15.64 6.41 -1.89 2.93 4.09 -11.66 -13.68 4.17 6.93 8.76 9.15
EBIT Less CapEx to Interest Expense
9.27 0.27 -7.40 -5.70 1.37 -19.46 -21.70 2.94 3.97 5.96 6.62
NOPAT Less CapEx to Interest Expense
3.99 -1.96 -6.60 -1.28 0.16 -14.87 -15.84 1.98 2.43 3.90 4.44
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
35.74% 113.30% -162.69% -183.61% 127.24% -27.40% -16.54% 36.26% 24.28% 30.81% 33.48%
Augmented Payout Ratio
120.70% 215.50% -210.51% -247.65% 145.61% -30.15% -16.78% 36.26% 24.28% 47.04% 71.41%

Quarterly Metrics And Ratios for SLB

This table displays calculated financial ratios and metrics derived from SLB's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
29.76% 19.58% 11.14% 14.10% 12.55% 12.84% 10.22% 3.27% -2.49% -6.49% -2.52%
EBITDA Growth
40.59% 26.85% 18.44% 12.70% 13.55% 10.53% 7.73% -1.25% -10.78% -13.86% -22.18%
EBIT Growth
66.81% 38.65% 22.86% 13.45% 16.86% 9.72% 6.62% -4.43% -18.33% -19.96% -31.22%
NOPAT Growth
66.41% 33.34% 23.46% 13.04% 16.30% 9.18% 5.82% -3.84% -21.28% -18.99% -34.13%
Net Income Growth
81.54% 7.94% 23.61% 6.00% 16.31% 9.36% 7.22% -2.61% -24.50% -8.47% -36.45%
EPS Growth
80.56% 7.46% 23.81% 4.11% 13.85% 6.94% 6.41% 1.32% -21.62% -3.90% -39.76%
Operating Cash Flow Growth
151.91% 294.12% 7.02% 87.24% -0.91% -10.70% 46.03% -20.91% 101.83% -20.47% -31.32%
Free Cash Flow Firm Growth
-35,935.27% 44.66% -55.16% -90.48% 40.05% -93.22% 21.42% 176.48% 189.66% 179.47% -470.58%
Invested Capital Growth
8.76% 6.45% 8.21% 8.01% 6.80% 8.44% 7.12% 1.56% 0.71% 0.10% 16.76%
Revenue Q/Q Growth
-1.82% 4.69% 2.61% 8.18% -3.15% 4.96% 0.22% 1.36% -8.55% 0.66% 4.47%
EBITDA Q/Q Growth
-5.10% 8.58% 6.90% 2.32% -4.38% 5.69% 4.19% -6.22% -13.60% 2.03% -5.86%
EBIT Q/Q Growth
-8.35% 12.82% 8.45% 1.17% -5.59% 5.92% 5.38% -9.31% -19.32% 3.80% -9.45%
NOPAT Q/Q Growth
-7.31% 12.35% 9.06% -0.47% -4.64% 5.48% 5.70% -9.55% -21.94% 8.55% -14.06%
Net Income Q/Q Growth
-12.83% 10.91% 8.50% 1.06% -4.36% 4.28% 6.38% -8.21% -25.85% 26.42% -26.15%
EPS Q/Q Growth
-10.96% 10.77% 8.33% -2.56% -2.63% 4.05% 7.79% -7.23% -24.68% 27.59% -32.43%
Operating Cash Flow Q/Q Growth
-79.55% 387.27% 4.29% 80.20% -89.18% 339.14% 70.54% -2.41% -72.38% 73.03% 47.29%
Free Cash Flow Firm Q/Q Growth
-163.59% 51.78% -54.23% 2.84% 17.05% -55.43% 37.28% 194.57% -2.75% 37.77% -550.34%
Invested Capital Q/Q Growth
5.89% 1.14% 0.08% 0.78% 4.71% 2.69% -1.15% -4.45% 3.83% 2.07% 15.31%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
18.76% 19.72% 20.67% 19.99% 19.52% 20.54% 20.98% 21.12% 18.92% 18.86% 17.45%
EBITDA Margin
22.61% 23.45% 24.43% 23.10% 22.81% 22.97% 23.88% 22.09% 20.87% 21.16% 19.06%
Operating Margin
15.33% 16.52% 17.46% 16.33% 15.92% 16.06% 16.89% 15.11% 13.33% 13.75% 11.92%
EBIT Margin
15.33% 16.52% 17.46% 16.33% 15.92% 16.06% 16.89% 15.11% 13.33% 13.75% 11.92%
Profit (Net Income) Margin
12.20% 12.93% 13.67% 12.77% 12.61% 12.53% 13.30% 12.04% 9.76% 12.26% 8.67%
Tax Burden Percent
81.31% 80.97% 81.43% 80.11% 80.91% 80.58% 80.82% 80.61% 77.99% 81.56% 77.40%
Interest Burden Percent
97.89% 96.64% 96.14% 97.62% 97.91% 96.80% 97.41% 98.86% 93.90% 109.36% 93.99%
Effective Tax Rate
18.69% 19.03% 18.57% 19.89% 19.09% 19.42% 19.18% 19.39% 22.01% 18.44% 22.60%
Return on Invested Capital (ROIC)
14.09% 15.45% 16.98% 16.03% 15.43% 15.67% 17.03% 15.62% 12.71% 13.17% 10.05%
ROIC Less NNEP Spread (ROIC-NNEP)
13.87% 15.06% 16.43% 15.65% 15.15% 15.22% 16.60% 15.42% 12.05% 14.25% 9.39%
Return on Net Nonoperating Assets (RNNOA)
7.68% 7.81% 7.24% 5.86% 6.25% 6.22% 5.98% 4.55% 4.62% 5.39% 2.85%
Return on Equity (ROE)
21.77% 23.26% 24.22% 21.89% 21.68% 21.89% 23.01% 20.17% 17.33% 18.56% 12.90%
Cash Return on Invested Capital (CROIC)
5.91% 8.73% 8.04% 8.59% 9.45% 7.96% 9.52% 15.01% 14.36% 13.88% -3.72%
Operating Return on Assets (OROA)
10.67% 11.76% 12.44% 11.88% 11.84% 11.99% 12.72% 11.32% 9.93% 9.94% 8.01%
Return on Assets (ROA)
8.49% 9.20% 9.74% 9.29% 9.38% 9.35% 10.02% 9.02% 7.27% 8.87% 5.83%
Return on Common Equity (ROCE)
21.38% 22.85% 23.81% 21.07% 20.88% 21.08% 22.17% 19.06% 16.35% 17.52% 12.25%
Return on Equity Simple (ROE_SIMPLE)
21.67% 21.46% 21.72% 0.00% 21.36% 21.48% 21.43% 0.00% 22.09% 20.75% 0.00%
Net Operating Profit after Tax (NOPAT)
964 1,083 1,182 1,176 1,121 1,183 1,250 1,131 883 958 824
NOPAT Margin
12.47% 13.38% 14.22% 13.08% 12.88% 12.94% 13.65% 12.18% 10.40% 11.21% 9.22%
Net Nonoperating Expense Percent (NNEP)
0.22% 0.40% 0.56% 0.38% 0.28% 0.45% 0.42% 0.20% 0.66% -1.08% 0.66%
Return On Investment Capital (ROIC_SIMPLE)
- - - 3.53% - - - 3.29% 2.54% 2.72% 2.08%
Cost of Revenue to Revenue
81.24% 80.28% 79.33% 80.01% 80.48% 79.46% 79.02% 78.88% 81.08% 81.14% 82.55%
SG&A Expenses to Revenue
1.18% 1.19% 0.97% 1.07% 1.39% 1.03% 0.98% 0.86% 1.13% 1.02% 0.81%
R&D to Revenue
2.25% 2.01% 2.24% 2.09% 2.09% 2.06% 2.04% 2.07% 2.03% 2.11% 1.90%
Operating Expenses to Revenue
3.43% 3.20% 3.21% 3.66% 3.61% 4.48% 4.09% 6.01% 5.58% 5.11% 5.53%
Earnings before Interest and Taxes (EBIT)
1,186 1,338 1,451 1,468 1,386 1,468 1,547 1,403 1,132 1,175 1,064
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,749 1,899 2,030 2,077 1,986 2,099 2,187 2,051 1,772 1,808 1,702
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.76 3.68 4.18 3.58 3.75 3.20 2.77 2.56 3.00 2.26 1.81
Price to Tangible Book Value (P/TBV)
35.11 27.17 24.07 25.21 22.32 20.17 15.55 15.36 30.58 16.71 13.12
Price to Revenue (P/Rev)
2.27 2.20 2.53 2.18 2.28 1.92 1.65 1.49 1.62 1.30 1.32
Price to Earnings (P/E)
17.57 17.40 19.48 17.19 17.92 15.27 13.30 12.14 13.98 11.24 12.74
Dividend Yield
1.62% 1.77% 1.62% 1.97% 1.88% 2.23% 2.56% 2.87% 2.66% 3.31% 3.29%
Earnings Yield
5.69% 5.75% 5.13% 5.82% 5.58% 6.55% 7.52% 8.24% 7.16% 8.90% 7.85%
Enterprise Value to Invested Capital (EV/IC)
2.80 2.78 3.20 2.84 2.92 2.52 2.26 2.14 2.30 1.84 1.58
Enterprise Value to Revenue (EV/Rev)
2.58 2.48 2.78 2.41 2.52 2.17 1.88 1.68 1.89 1.56 1.57
Enterprise Value to EBITDA (EV/EBITDA)
11.32 10.75 11.84 10.29 10.76 9.30 8.08 7.34 8.42 7.10 7.53
Enterprise Value to EBIT (EV/EBIT)
16.65 15.49 16.90 14.66 15.24 13.19 11.50 10.53 12.30 10.56 11.57
Enterprise Value to NOPAT (EV/NOPAT)
20.38 19.14 20.86 18.11 18.85 16.34 14.27 13.05 15.35 13.14 14.53
Enterprise Value to Operating Cash Flow (EV/OCF)
19.65 15.12 17.03 12.02 12.96 11.78 9.33 9.26 9.84 8.36 9.40
Enterprise Value to Free Cash Flow (EV/FCFF)
49.34 32.85 41.32 34.34 31.98 32.95 24.56 14.39 16.10 13.23 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.70 0.70 0.67 0.56 0.56 0.59 0.57 0.54 0.67 0.64 0.47
Long-Term Debt to Equity
0.58 0.60 0.57 0.51 0.49 0.55 0.52 0.49 0.51 0.51 0.40
Financial Leverage
0.55 0.52 0.44 0.37 0.41 0.41 0.36 0.30 0.38 0.38 0.30
Leverage Ratio
2.52 2.47 2.42 2.32 2.28 2.29 2.25 2.22 2.27 2.24 2.11
Compound Leverage Factor
2.47 2.38 2.32 2.26 2.23 2.21 2.19 2.19 2.13 2.45 1.99
Debt to Total Capital
41.12% 41.32% 40.01% 35.91% 35.70% 37.18% 36.25% 35.07% 40.29% 38.86% 32.17%
Short-Term Debt to Total Capital
6.86% 6.18% 6.08% 3.37% 4.19% 2.91% 2.97% 3.05% 10.00% 7.96% 4.85%
Long-Term Debt to Total Capital
34.27% 35.15% 33.93% 32.54% 31.50% 34.27% 33.28% 32.02% 30.29% 30.90% 27.32%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.00% 1.01% 0.98% 3.51% 3.48% 3.41% 3.41% 3.54% 3.55% 3.54% 3.24%
Common Equity to Total Capital
57.88% 57.67% 59.01% 60.58% 60.82% 59.41% 60.34% 61.38% 56.16% 57.60% 64.59%
Debt to EBITDA
1.89 1.85 1.75 1.54 1.52 1.61 1.55 1.45 1.73 1.75 1.74
Net Debt to EBITDA
1.29 1.19 1.04 0.82 0.89 0.92 0.80 0.69 1.04 1.06 1.02
Long-Term Debt to EBITDA
1.57 1.57 1.48 1.40 1.34 1.48 1.42 1.32 1.30 1.39 1.48
Debt to NOPAT
3.40 3.30 3.08 2.72 2.67 2.83 2.73 2.58 3.15 3.24 3.36
Net Debt to NOPAT
2.32 2.11 1.82 1.44 1.55 1.61 1.42 1.23 1.90 1.96 1.97
Long-Term Debt to NOPAT
2.83 2.80 2.61 2.46 2.35 2.61 2.51 2.35 2.37 2.58 2.85
Altman Z-Score
2.82 2.86 3.17 2.92 3.14 2.87 2.74 2.67 2.62 2.43 2.26
Noncontrolling Interest Sharing Ratio
1.78% 1.76% 1.70% 3.75% 3.72% 3.72% 3.62% 5.47% 5.67% 5.61% 5.04%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.26 1.33 1.36 1.32 1.37 1.49 1.48 1.45 1.24 1.31 1.39
Quick Ratio
0.82 0.89 0.94 0.88 0.91 1.02 1.00 0.99 0.83 0.88 0.90
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-1,254 -605 -932 -906 -752 -1,168 -733 693 674 928 -4,180
Operating Cash Flow to CapEx
71.43% 320.32% 334.06% 308.37% 76.40% 273.52% 480.20% 251.31% 165.83% 307.82% 411.25%
Free Cash Flow to Firm to Interest Expense
-10.72 -4.76 -7.23 -6.97 -6.65 -8.85 -5.39 5.29 4.58 6.54 -29.44
Operating Cash Flow to Interest Expense
2.82 12.66 13.00 23.25 2.89 10.88 18.01 18.24 4.49 8.04 11.85
Operating Cash Flow Less CapEx to Interest Expense
-1.13 8.71 9.11 15.71 -0.89 6.90 14.26 10.98 1.78 5.43 8.96
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.70 0.71 0.71 0.73 0.74 0.75 0.75 0.75 0.74 0.72 0.67
Accounts Receivable Turnover
4.49 4.48 4.36 4.55 4.32 4.32 4.41 4.59 4.29 4.13 4.06
Inventory Turnover
6.05 6.04 6.08 6.34 6.18 6.33 6.47 6.58 6.24 6.14 5.76
Fixed Asset Turnover
4.58 4.73 4.82 4.79 4.89 4.97 5.06 4.97 4.92 4.82 4.59
Accounts Payable Turnover
2.79 2.88 2.81 2.65 2.91 2.95 2.93 2.71 2.83 2.82 2.69
Days Sales Outstanding (DSO)
81.22 81.46 83.77 80.29 84.55 84.54 82.69 79.58 85.13 88.43 89.89
Days Inventory Outstanding (DIO)
60.36 60.47 60.02 57.60 59.07 57.66 56.46 55.47 58.48 59.45 63.33
Days Payable Outstanding (DPO)
130.74 126.81 129.71 137.53 125.38 123.84 124.44 134.71 128.88 129.21 135.72
Cash Conversion Cycle (CCC)
10.84 15.11 14.08 0.35 18.24 18.36 14.71 0.34 14.73 18.66 17.50
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
27,534 27,847 27,868 28,085 29,407 30,198 29,851 28,523 29,616 30,228 34,855
Invested Capital Turnover
1.13 1.16 1.19 1.23 1.20 1.21 1.25 1.28 1.22 1.17 1.09
Increase / (Decrease) in Invested Capital
2,218 1,688 2,114 2,082 1,873 2,351 1,983 438 209 30 5,004
Enterprise Value (EV)
77,004 77,422 89,050 79,777 86,000 76,153 67,496 61,132 68,253 55,497 55,219
Market Capitalization
67,912 68,556 80,941 72,255 77,740 67,436 59,562 54,142 58,556 45,973 46,442
Book Value per Share
$12.72 $13.06 $13.64 $14.18 $14.53 $14.74 $15.15 $14.96 $13.93 $14.93 $18.97
Tangible Book Value per Share
$1.36 $1.77 $2.37 $2.01 $2.44 $2.34 $2.70 $2.50 $1.37 $2.02 $2.62
Total Capital
31,218 32,269 32,852 33,324 34,093 35,469 35,651 34,424 34,750 35,249 39,688
Total Debt
12,838 13,335 13,145 11,965 12,170 13,189 12,923 12,074 14,002 13,698 12,766
Total Long-Term Debt
10,698 11,342 11,147 10,842 10,740 12,156 11,864 11,023 10,527 10,891 10,843
Net Debt
8,780 8,540 7,788 6,352 7,073 7,508 6,717 5,770 8,464 8,275 7,490
Capital Expenditures (CapEx)
462 502 502 980 428 525 510 951 398 371 409
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,784 2,790 2,773 1,457 2,760 3,138 2,699 2,141 3,137 3,478 3,769
Debt-free Net Working Capital (DFNWC)
5,288 5,984 6,508 5,446 6,251 7,141 7,161 6,810 7,034 7,225 7,354
Net Working Capital (NWC)
3,148 3,991 4,510 4,323 4,821 6,108 6,102 5,759 3,559 4,418 5,431
Net Nonoperating Expense (NNE)
20 36 46 28 23 38 32 13 54 -90 50
Net Nonoperating Obligations (NNO)
9,154 8,913 8,161 6,726 7,484 7,918 7,123 6,173 8,868 8,677 7,933
Total Depreciation and Amortization (D&A)
563 561 579 609 600 631 640 648 640 633 638
Debt-free, Cash-free Net Working Capital to Revenue
9.32% 8.94% 8.66% 4.40% 8.09% 8.93% 7.50% 5.90% 8.70% 9.80% 10.69%
Debt-free Net Working Capital to Revenue
17.71% 19.19% 20.32% 16.44% 18.33% 20.32% 19.89% 18.77% 19.50% 20.36% 20.86%
Net Working Capital to Revenue
10.54% 12.80% 14.08% 13.05% 14.14% 17.38% 16.95% 15.87% 9.87% 12.45% 15.41%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.65 $0.73 $0.79 $0.78 $0.75 $0.78 $0.84 $0.77 $0.58 $0.75 $0.50
Adjusted Weighted Average Basic Shares Outstanding
1.43B 1.42B 1.42B 1.43B 1.43B 1.43B 1.42B 1.42B 1.37B 1.35B 1.47B
Adjusted Diluted Earnings per Share
$0.65 $0.72 $0.78 $0.76 $0.74 $0.77 $0.83 $0.77 $0.58 $0.74 $0.50
Adjusted Weighted Average Diluted Shares Outstanding
1.45B 1.44B 1.44B 1.44B 1.45B 1.44B 1.43B 1.44B 1.38B 1.37B 1.49B
Adjusted Basic & Diluted Earnings per Share
$0.65 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.75 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.43B 1.42B 1.42B 1.43B 1.43B 1.42B 1.41B 1.40B 1.36B 1.35B 1.49B
Normalized Net Operating Profit after Tax (NOPAT)
964 1,083 1,182 1,212 1,130 1,285 1,330 1,361 1,043 1,097 1,019
Normalized NOPAT Margin
12.47% 13.38% 14.22% 13.48% 12.98% 14.06% 14.52% 14.66% 12.29% 12.84% 11.41%
Pre Tax Income Margin
15.01% 15.96% 16.79% 15.94% 15.59% 15.55% 16.45% 14.94% 12.52% 15.04% 11.20%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
10.14 10.54 11.25 11.29 12.27 11.12 11.38 10.71 7.70 8.27 7.49
NOPAT to Interest Expense
8.24 8.53 9.16 9.05 9.92 8.96 9.19 8.63 6.01 6.75 5.80
EBIT Less CapEx to Interest Expense
6.19 6.58 7.36 3.75 8.48 7.14 7.63 3.45 4.99 5.66 4.61
NOPAT Less CapEx to Interest Expense
4.29 4.58 5.27 1.51 6.14 4.98 5.44 1.37 3.30 4.14 2.92
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
23.54% 27.57% 28.72% 30.81% 32.17% 32.32% 32.55% 33.48% 36.24% 36.91% 41.52%
Augmented Payout Ratio
29.42% 38.67% 42.83% 47.04% 48.75% 54.10% 61.53% 71.41% 123.64% 115.29% 118.86%

Financials Breakdown Chart

Key Financial Trends

Schlumberger Limited (NYSE: SLB) has demonstrated steady financial performance and solid operational metrics over the past few years, based on the analysis of income statements, balance sheets, and cash flow statements from 2022 through Q3 2025.

Positive financial trends and highlights:

  • Consistent growth in operating revenue and total revenue, reaching $8.93 billion in Q3 2025, up from $7.48 billion in Q3 2022, reflecting robust demand for Schlumberger's services.
  • Net income from continuing operations has shown a generally upward trend, with Q3 2025 reporting $774 million and full-year 2024 net income just above $4.5 billion, indicating steady profitability.
  • Gross profit margins have remained relatively stable, with total gross profit approximately $1.56 billion in Q3 2025 compared to $1.44 billion in Q3 2022, signaling effective cost management.
  • Depreciation expenses have been stable around $600 million per quarter, reflecting steady capital investment returns.
  • Cash and equivalents increased significantly from $1.5 billion in Q1 2023 to $3.0 billion by Q3 2025, improving liquidity position.
  • Total equity and noncontrolling interests have increased from $18.0 billion in Q1 2023 to $25.6 billion by Q3 2025, signaling strong equity growth and capital base expansion.
  • Operating cash flow improved markedly from $330 million in Q1 2023 to $1.68 billion in Q3 2025, supporting operational sustainability and investments.
  • Repayment of debt activities in Q3 2025 totaled about $1.1 billion, indicating progress in deleveraging the balance sheet.
  • SLB continues investing in property, plant, and equipment with consistent CapEx around $400 million per quarter, supporting future growth.
  • Dividends paid have increased moderately over the period, reflecting management’s confidence in cash generation and willingness to return capital to shareholders.

Neutral observations:

  • Fluctuations in acquisitions and sales of investments are evident but do not show a clear trend impacting long-term financial health.
  • Accounts receivable and inventories have grown in line with revenue increases, suggesting business expansion but also requiring monitoring of working capital efficiency.
  • Non-cash adjustments to net income and restructuring charges vary each quarter, reflecting ongoing operational optimizations.
  • Interest expenses around $130-$140 million per quarter have remained steady, balanced by interest and investment income.
  • Weighted average share count has increased modestly, diluting EPS slightly despite income growth.

Negative considerations:

  • Net cash used in financing activities is consistently negative, with significant repurchases of common equity e.g., $1.14 billion in Q3 2025, which might constrain liquidity.
  • Total liabilities have increased from about $25.8 billion in Q1 2023 to over $28 billion by Q3 2025, mainly due to long-term debt remaining above $10 billion, which could add financial risk.
  • Accumulated other comprehensive losses have grown to almost -$4.8 billion, representing potential unrealized losses affecting shareholder equity.
  • Restructuring charges have increased to $252 million in Q3 2025 from lower levels in prior years, indicating ongoing costs related to strategic business adjustments.

Summary: Schlumberger has shown healthy revenue growth paired with consistent profitability and strong cash flow generation in the recent years. The company maintains a robust asset base and is actively managing debt and shareholder returns. Investors should note the continued equity repurchases and increasing liabilities but balanced by strong operating cash flows and expanding equity. Continued focus on operational efficiencies and capital discipline will be critical to sustaining this positive momentum.

10/24/25 11:20 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About SLB's Financials

When does SLB's financial year end?

According to the most recent income statement we have on file, SLB's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has SLB's net income changed over the last 10 years?

SLB's net income appears to be on an upward trend, with a most recent value of $4.58 billion in 2024, falling from $5.51 billion in 2014. The previous period was $4.28 billion in 2023. See where experts think SLB is headed by visiting SLB's forecast page.

What is SLB's operating income?
SLB's total operating income in 2024 was $5.80 billion, based on the following breakdown:
  • Total Gross Profit: $7.46 billion
  • Total Operating Expenses: $1.66 billion
How has SLB's revenue changed over the last 10 years?

Over the last 10 years, SLB's total revenue changed from $48.58 billion in 2014 to $36.29 billion in 2024, a change of -25.3%.

How much debt does SLB have?

SLB's total liabilities were at $26.59 billion at the end of 2024, a 0.0% decrease from 2023, and a 7.9% decrease since 2014.

How much cash does SLB have?

In the past 10 years, SLB's cash and equivalents has ranged from $844 million in 2020 to $3.54 billion in 2024, and is currently $3.54 billion as of their latest financial filing in 2024.

How has SLB's book value per share changed over the last 10 years?

Over the last 10 years, SLB's book value per share changed from 29.41 in 2014 to 14.96 in 2024, a change of -49.1%.



This page (NYSE:SLB) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners